Search results
Showing 901 to 915 of 1515 results for patients and public
In development Reference number: GID-TA11590 Expected publication date: TBC
In development Reference number: GID-TA11813 Expected publication date: TBC
Nipocalimab for treating generalised myasthenia gravis [ID6562]
In development Reference number: GID-TA11492 Expected publication date: TBC
In development Reference number: GID-TA11776 Expected publication date: TBC
In development Reference number: GID-TA11869 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 19 February 2026.
Aficamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6668]
Awaiting development Reference number: GID-TA11877 Expected publication date: TBC
Awaiting development Reference number: GID-TA11847 Expected publication date: TBC
This is the user guide for submission of evidence to the National Institute for Health and Care Excellence (NICE) as part of the single technology appraisal and highly specialised technologies evaluations process. It explains what information NICE requires and the format in which it should be presented
This quality standard covers care and support and services for children, young people and adults with a learning disability (or a learning disability and autism) and behaviour that challenges, and their families and carers. It describes high quality care in priority areas for improvement.
View quality statements for QS101Show all sections
Sections for QS101
- Quality statements
- Quality statement 1: Lead commissioner
- Quality statement 2: Annual health check
- Quality statement 3: Initial assessment of behaviour that challenges
- Quality statement 4: Named lead practitioner
- Quality statement 5: Involving families and carers
- Quality statement 6: Parent-training programmes
- Quality statement 7: Personalised daily activities
In development Reference number: GID-TA11499 Expected publication date: TBC
Awaiting development Reference number: GID-TA11281 Expected publication date: TBC
In development Reference number: GID-TA11644 Expected publication date: 22 October 2026
In development Reference number: GID-TA11766 Expected publication date: TBC
In development Reference number: GID-TA11342 Expected publication date: TBC